Dhansa Labs Ltd
Incorporated in 1985, Ambey Laboratories Ltd is in the business of manufacturing and distribution of agro and home hygiene products.[1]
- Market Cap ₹ 56.1 Cr.
- Current Price ₹ 22.5
- High / Low ₹ 48.3 / 16.2
- Stock P/E 10.2
- Book Value ₹ 39.6
- Dividend Yield 0.00 %
- ROCE %
- ROE 5.58 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.57 times its book value
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of Nifty SME Emerge
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| 142 | |
| 131 | |
| Operating Profit | 11 |
| OPM % | 8% |
| 1 | |
| Interest | 3 |
| Depreciation | 2 |
| Profit before tax | 7 |
| Tax % | 25% |
| 6 | |
| EPS in Rs | 2.21 |
| Dividend Payout % | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -44% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 6% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| Equity Capital | 25 |
| Reserves | 74 |
| 40 | |
| 12 | |
| Total Liabilities | 151 |
| 24 | |
| CWIP | 23 |
| Investments | 0 |
| 104 | |
| Total Assets | 151 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| -4 | |
| -48 | |
| 54 | |
| Net Cash Flow | 1 |
| Free Cash Flow | -54 |
| CFO/OP | -31% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| Debtor Days | 139 |
| Inventory Days | 89 |
| Days Payable | 18 |
| Cash Conversion Cycle | 210 |
| Working Capital Days | 170 |
| ROCE % |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtors Turnover Ratio times ・Standalone data |
|
||
| Installed Production Capacity: 2,4-D MT ・Standalone data |
|||
| Installed Production Capacity: Metribuzin MT ・Standalone data |
|||
| Installed Production Capacity: Pretilachlor MT ・Standalone data |
|||
| Number of Customers Numbers ・Standalone data |
|||
| Total Installed Capacity (Agrochemicals & Intermediates) MT ・Standalone data |
|||
| Total Product and Combination Registrations Numbers ・Standalone data |
|||
| Cash Conversion Cycle days ・Standalone data |
|||
Extracted by Screener AI
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
11 June 2026 - Q4 FY26 earnings call transcript details ₹30 crore Atrazine capex and ₹240 crore CBG/Biofuel plans.
-
Analysts/Institutional Investor Meet/Con. Call Updates
6 June 2026 - Audio recording of 5 June 2026 earnings call for Q4 and FY2025-26 results uploaded.
-
Investor Presentation
5 June 2026 - FY26 audited results: revenue ₹141.54 crore, EBITDA ₹12.22 crore, PAT ₹5.52 crore; expansion and CBG projects outlined.
-
Analysts/Institutional Investor Meet/Con. Call Updates
2 June 2026 - Q4 FY2026 earnings conference call scheduled for 5 June 2026 at 5:00 PM IST.
-
Copy of Newspaper Publication
31 May 2026 - Newspaper advertisement for Q4, half-year and FY2026 standalone/consolidated financial results published on May 31, 2026.
Annual reports
Concalls
-
Jun 2026TranscriptPPTREC
Business Overview:[1][2]
ALL is the 3rd-largest manufacturer of 2,4-D in India. It manufactures
herbicides and home hygiene products, with a high concentration in agrochemicals.
The portfolio currently comprises ~11 agrochemical and ~10 hygiene products,
with 2 additional agrochemical products being introduced. The company has over
200 product and combination registrations. The company has a client base of 250+ customers.